Can we predict sudden cardiac death after a heart attack? new study aims to find out

NCT ID NCT07545512

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will follow 400 people who had a heart attack and have moderately reduced heart function (ejection fraction 35-50%). Participants will get a small implantable heart monitor to track their heart rhythm for up to 5 years. The goal is to identify markers that could predict who is at risk of sudden cardiac death, so doctors can better decide who needs a defibrillator.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to better tools to predict who is at risk of sudden cardiac death after a heart attack, helping doctors decide who needs a defibrillator.
What could go wrong
This is an observational study, not a treatment trial. It may not find clear markers, and results may not change practice for years. The implantable monitor carries small risks like infection or discomfort.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYOCARDIAL INFARCTION (MI) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • APHP - Hôpital européen Georges-Pompidou

    Paris, France

    Contact

  • CH Vichy

    Vichy, France

    Contact

  • CHU Amiens

    Amiens, France

    Contact

  • CHU Brest

    Brest, France

    Contact

  • CHU Clermont-Ferrand

    Clermont-Ferrand, 63000, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • CHU Nancy

    Nancy, France

    Contact

  • CHU Saint Etienne

    Saint-Etienne, France

    Contact

  • CHU Toulouse

    Toulouse, France

    Contact

  • HCL - Hôpital Pierre Wertheimer

    Lyon, France

    Contact

  • HCL - Hôpital de la Croix-Rousse

    Lyon, France

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.